Biosimilar Monoclonal Antibodies Market
Table of Contents
Chapter 1 Biosimilar Monoclonal Antibodies (mAbs) Market Overview
1.1 Biosimilar Monoclonal Antibodies (mAbs) Definition
1.2 Global Biosimilar Monoclonal Antibodies (mAbs) Market Size Status and Outlook (2017-2031)
1.3 Global Biosimilar Monoclonal Antibodies (mAbs) Market Size Comparison by Region (2017-2031)
1.4 Global Biosimilar Monoclonal Antibodies (mAbs) Market Size Comparison by Type (2017-2031)
1.5 Global Biosimilar Monoclonal Antibodies (mAbs) Market Size Comparison by Application (2017-2031)
1.6 Global Biosimilar Monoclonal Antibodies (mAbs) Market Size Comparison by Sales Channel (2017-2031)
1.7 Biosimilar Monoclonal Antibodies (mAbs) Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/Expansion)
1.7.4 COVID-19 Impacts
1.7.5 Russia-Ukraine War Impacts
Chapter 2 Biosimilar Monoclonal Antibodies (mAbs) Market Segment Analysis by Player
2.1 Global Biosimilar Monoclonal Antibodies (mAbs) Sales and Market Share by Player (2020-2022)
2.2 Global Biosimilar Monoclonal Antibodies (mAbs) Revenue and Market Share by Player (2020-2022)
2.3 Global Biosimilar Monoclonal Antibodies (mAbs) Average Price by Player (2020-2022)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Biosimilar Monoclonal Antibodies (mAbs) Market Segment Analysis by Type
3.1 Global Biosimilar Monoclonal Antibodies (mAbs) Market by Type
3.1.1 Infliximab
3.1.2 Rituximab
3.1.3 Trastuzumab
3.1.4 Adalimumab
3.1.5 Others
3.2 Global Biosimilar Monoclonal Antibodies (mAbs) Sales and Market Share by Type (2017-2022)
3.3 Global Biosimilar Monoclonal Antibodies (mAbs) Revenue and Market Share by Type (2017-2022)
3.4 Global Biosimilar Monoclonal Antibodies (mAbs) Average Price by Type (2017-2022)
3.5 Leading Players of Biosimilar Monoclonal Antibodies (mAbs) by Type in 2022
3.6 Conclusion of Segment by Type
Chapter 4 Biosimilar Monoclonal Antibodies (mAbs) Market Segment Analysis by Application
4.1 Global Biosimilar Monoclonal Antibodies (mAbs) Market by Application
4.1.1 Oncology
4.1.2 Autoimmune Disease
4.1.3 Others
4.2 Global Biosimilar Monoclonal Antibodies (mAbs) Revenue and Market Share by Application (2017-2022)
4.3 Leading Consumers of Biosimilar Monoclonal Antibodies (mAbs) by Application in 2022
4.4 Conclusion of Segment by Application
Chapter 5 Biosimilar Monoclonal Antibodies (mAbs) Market Segment Analysis by Sales Channel
5.1 Global Biosimilar Monoclonal Antibodies (mAbs) Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Biosimilar Monoclonal Antibodies (mAbs) Revenue and Market Share by Sales Channel (2017-2022)
5.3 Leading Distributors/Dealers of Biosimilar Monoclonal Antibodies (mAbs) by Sales Channel in 2022
5.4 Conclusion of Segment by Sales Channel
Chapter 6 Biosimilar Monoclonal Antibodies (mAbs) Market Segment Analysis by Region
6.1 Global Biosimilar Monoclonal Antibodies (mAbs) Market Size and CAGR by Region (2017-2031)
6.2 Global Biosimilar Monoclonal Antibodies (mAbs) Sales and Market Share by Region (2017-2022)
6.3 Global Biosimilar Monoclonal Antibodies (mAbs) Revenue and Market Share by Region (2017-2022)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Biosimilar Monoclonal Antibodies (mAbs) Market Share by Type
6.4.3 North America Biosimilar Monoclonal Antibodies (mAbs) Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Biosimilar Monoclonal Antibodies (mAbs) Market Share by Type
6.5.3 Europe Biosimilar Monoclonal Antibodies (mAbs) Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Biosimilar Monoclonal Antibodies (mAbs) Market Share by Type
6.6.3 Asia-Pacific Biosimilar Monoclonal Antibodies (mAbs) Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Biosimilar Monoclonal Antibodies (mAbs) Market Share by Type
6.7.3 South America Biosimilar Monoclonal Antibodies (mAbs) Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Biosimilar Monoclonal Antibodies (mAbs) Market Share by Type
6.8.3 Middle East & Africa Biosimilar Monoclonal Antibodies (mAbs) Market Share by Application
6.8.4 UAE
6.8.5 Saudi Arabia
6.8.6 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Biosimilar Monoclonal Antibodies (mAbs) Players
7.1 Celltrion
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.2 Pfizer (Hospira)
7.3 3SBIO
7.4 Novartis (Sandoz)
7.5 Dr Reddy?s
7.6 Celgen Biopharma
7.7 Cadila Healthcare
7.8 Hisun Pharma
7.9 Torrent Pharmaceuticals
7.10 Biocon
Chapter 8 Upstream and Downstream Analysis of Biosimilar Monoclonal Antibodies (mAbs)
8.1 Industrial Chain of Biosimilar Monoclonal Antibodies (mAbs)
8.2 Upstream of Biosimilar Monoclonal Antibodies (mAbs)
8.3 Downstream of Biosimilar Monoclonal Antibodies (mAbs)
Chapter 9 Development Trend of Biosimilar Monoclonal Antibodies (mAbs) (2023-2031)
9.1 Global Biosimilar Monoclonal Antibodies (mAbs) Market Size (Sales and Revenue) Forecast (2023-2031)
9.2 Global Biosimilar Monoclonal Antibodies (mAbs) Market Size and CAGR Forecast by Region (2023-2031)
9.3 Global Biosimilar Monoclonal Antibodies (mAbs) Market Size and CAGR Forecast by Type (2023-2031)
9.4 Global Biosimilar Monoclonal Antibodies (mAbs) Market Size and CAGR Forecast by Application (2023-2031)
9.5 Global Biosimilar Monoclonal Antibodies (mAbs) Market Size and CAGR Forecast by Sales Channel (2023-2031)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
List of Tables and Figures
Figure Biosimilar Monoclonal Antibodies (mAbs) Example
Figure Global Biosimilar Monoclonal Antibodies (mAbs) Revenue (Million $) Status and Outlook (2017-2031)
Figure Global Biosimilar Monoclonal Antibodies (mAbs) Revenue (Million $) Comparison by Region (2017-2031)
Figure Global Biosimilar Monoclonal Antibodies (mAbs) Revenue (Million $) Comparison by Type (2017-2031)
Figure Global Biosimilar Monoclonal Antibodies (mAbs) Revenue (Million $) Comparison by Application (2017-2031)
Figure Global Biosimilar Monoclonal Antibodies (mAbs) Revenue (Million $) Comparison by Sales Channel (2017-2031)
Table Global Biosimilar Monoclonal Antibodies (mAbs) Sales by Player (2020-2022)
Table Global Biosimilar Monoclonal Antibodies (mAbs) Sales Market Share by Player (2020-2022)
Figure Global Biosimilar Monoclonal Antibodies (mAbs) Sales Market Share by Player in 2022
Table Global Biosimilar Monoclonal Antibodies (mAbs) Revenue (Million $) by Player (2020-2022)
Table Global Biosimilar Monoclonal Antibodies (mAbs) Revenue Market Share by Player (2020-2022)
Figure Global Biosimilar Monoclonal Antibodies (mAbs) Revenue Market Share by Player in 2022
Table Global Biosimilar Monoclonal Antibodies (mAbs) Average Price by Player (2020-2022)
Figure Global Biosimilar Monoclonal Antibodies (mAbs) Average Price by Player in 2022
Figure Global Biosimilar Monoclonal Antibodies (mAbs) Players Competition Situation ? Top 5 Players? Revenue Market Share in 2020
Figure Global Biosimilar Monoclonal Antibodies (mAbs) Players Competition Trends ? Top 5 Players? Revenue Market Share in 2022
Figure Example of Infliximab
Figure Global Infliximab Revenue (Million $) and Growth Rate (2017-2022)
Figure Example of Rituximab
Figure Global Rituximab Revenue (Million $) and Growth Rate (2017-2022)
Figure Example of Trastuzumab
Figure Global Trastuzumab Revenue (Million $) and Growth Rate (2017-2022)
Figure Example of Adalimumab
Figure Global Adalimumab Revenue (Million $) and Growth Rate (2017-2022)
Figure Example of Others
Figure Global Others Revenue (Million $) and Growth Rate (2017-2022)
Table Global Biosimilar Monoclonal Antibodies (mAbs) Sales by Type (2017-2022)
Table Global Biosimilar Monoclonal Antibodies (mAbs) Sales Market Share by Type (2017-2022)
Figure Global Biosimilar Monoclonal Antibodies (mAbs) Sales Market Share by Type in 2022
Table Global Biosimilar Monoclonal Antibodies (mAbs) Revenue (Million $) by Type (2017-2022)
Table Global Biosimilar Monoclonal Antibodies (mAbs) Revenue Market Share by Type (2017-2022)
Figure Global Biosimilar Monoclonal Antibodies (mAbs) Revenue Market Share by Type in 2022
Table Global Biosimilar Monoclonal Antibodies (mAbs) Average Price by Type (2017-2022)
Figure Global Biosimilar Monoclonal Antibodies (mAbs) Average Price by Type in 2022
Table Leading Players of Biosimilar Monoclonal Antibodies (mAbs) by Type in 2022
Figure Example of Oncology
Figure Global Biosimilar Monoclonal Antibodies (mAbs) for Oncology Revenue (Million $) and Growth Rate (2017-2022)
Figure Example of Autoimmune Disease
Figure Global Biosimilar Monoclonal Antibodies (mAbs) for Autoimmune Disease Revenue (Million $) and Growth Rate (2017-2022)
Figure Example of Others
Figure Global Biosimilar Monoclonal Antibodies (mAbs) for Others Revenue (Million $) and Growth Rate (2017-2022)
Table Global Biosimilar Monoclonal Antibodies (mAbs) Sales by Application (2017-2022)
Table Global Biosimilar Monoclonal Antibodies (mAbs) Sales Market Share by Application (2017-2022)
Figure Global Biosimilar Monoclonal Antibodies (mAbs) Sales Market Share by Application in 2022
Table Leading Consumers of Biosimilar Monoclonal Antibodies (mAbs) by Application in 2022
Figure Example of Direct Channel
Figure Global Biosimilar Monoclonal Antibodies (mAbs) for Direct Channel Revenue (Million $) and Growth Rate (2017-2022)
Figure Example of Distribution Channel
Figure Global Biosimilar Monoclonal Antibodies (mAbs) for Distribution Channel Revenue (Million $) and Growth Rate (2017-2022)
Table Global Biosimilar Monoclonal Antibodies (mAbs) Revenue by Sales Channel (2017-2022)
Table Global Biosimilar Monoclonal Antibodies (mAbs) Revenue Market Share by Sales Channel (2017-2022)
Figure Global Biosimilar Monoclonal Antibodies (mAbs) Revenue Market Share by Sales Channel in 2022
Table Leading Distributors/Dealers of Biosimilar Monoclonal Antibodies (mAbs) by Sales Channel in 2022
Table Global Biosimilar Monoclonal Antibodies (mAbs) Market Size and CAGR by Region (2017-2031)
Table Global Biosimilar Monoclonal Antibodies (mAbs) Sales by Region (2017-2022)
Table Global Biosimilar Monoclonal Antibodies (mAbs) Sales Market Share by Region (2017-2022)
Figure Global Biosimilar Monoclonal Antibodies (mAbs) Sales Market Share by Region in 2022
Table Global Biosimilar Monoclonal Antibodies (mAbs) Revenue (Million $) by Region (2017-2022)
Table Global Biosimilar Monoclonal Antibodies (mAbs) Revenue Market Share by Region (2017-2022)
Figure Global Biosimilar Monoclonal Antibodies (mAbs) Revenue Market Share by Region in 2022
Table North America Biosimilar Monoclonal Antibodies (mAbs) Sales by Country (2017-2022)
Figure North America Biosimilar Monoclonal Antibodies (mAbs) Sales Market Share by Country (2017-2022)
Table North America Biosimilar Monoclonal Antibodies (mAbs) Revenue by Country (2017-2022)
Figure North America Biosimilar Monoclonal Antibodies (mAbs) Revenue Market Share by Country (2017-2022)
Figure North America Biosimilar Monoclonal Antibodies (mAbs) Market Share by Type in 2022
Figure North America Biosimilar Monoclonal Antibodies (mAbs) Market Share by Application in 2022
Figure United States Biosimilar Monoclonal Antibodies (mAbs) Sales and Growth Rate (2017-2022)
Figure United States Biosimilar Monoclonal Antibodies (mAbs) Revenue (Million $) and Growth Rate (2017-2022)
Figure Canada Biosimilar Monoclonal Antibodies (mAbs) Sales and Growth Rate (2017-2022)
Figure Canada Biosimilar Monoclonal Antibodies (mAbs) Revenue (Million $) and Growth Rate (2017-2022)
Figure Mexico Biosimilar Monoclonal Antibodies (mAbs) Sales and Growth Rate (2017-2022)
Figure Mexico Biosimilar Monoclonal Antibodies (mAbs) Revenue (Million $) and Growth Rate (2017-2022)
Table Europe Biosimilar Monoclonal Antibodies (mAbs) Sales by Country (2017-2022)
Figure Europe Biosimilar Monoclonal Antibodies (mAbs) Sales Market Share by Country (2017-2022)
Table Europe Biosimilar Monoclonal Antibodies (mAbs) Revenue by Country (2017-2022)
Figure Europe Biosimilar Monoclonal Antibodies (mAbs) Revenue Market Share by Country (2017-2022)
Figure Europe Biosimilar Monoclonal Antibodies (mAbs) Market Share by Type in 2022
Figure Europe Biosimilar Monoclonal Antibodies (mAbs) Market Share by Application in 2022
Figure Germany Biosimilar Monoclonal Antibodies (mAbs) Sales and Growth Rate (2017-2022)
Figure Germany Biosimilar Monoclonal Antibodies (mAbs) Revenue (Million $) and Growth Rate (2017-2022)
Figure UK Biosimilar Monoclonal Antibodies (mAbs) Sales and Growth Rate (2017-2022)
Figure UK Biosimilar Monoclonal Antibodies (mAbs) Revenue (Million $) and Growth Rate (2017-2022)
Figure France Biosimilar Monoclonal Antibodies (mAbs) Sales and Growth Rate (2017-2022)
Figure France Biosimilar Monoclonal Antibodies (mAbs) Revenue (Million $) and Growth Rate (2017-2022)
Figure Italy Biosimilar Monoclonal Antibodies (mAbs) Sales and Growth Rate (2017-2022)
Figure Italy Biosimilar Monoclonal Antibodies (mAbs) Revenue (Million $) and Growth Rate (2017-2022)
Figure Russia Biosimilar Monoclonal Antibodies (mAbs) Sales and Growth Rate (2017-2022)
Figure Russia Biosimilar Monoclonal Antibodies (mAbs) Revenue (Million $) and Growth Rate (2017-2022)
Figure Spain Biosimilar Monoclonal Antibodies (mAbs) Sales and Growth Rate (2017-2022)
Figure Spain Biosimilar Monoclonal Antibodies (mAbs) Revenue (Million $) and Growth Rate (2017-2022)
Table Asia-Pacific Biosimilar Monoclonal Antibodies (mAbs) Sales by Country (2017-2022)
Figure Asia-Pacific Biosimilar Monoclonal Antibodies (mAbs) Sales Market Share by Country (2017-2022)
Table Asia-Pacific Biosimilar Monoclonal Antibodies (mAbs) Revenue by Country (2017-2022)
Figure Asia-Pacific Biosimilar Monoclonal Antibodies (mAbs) Revenue Market Share by Country (2017-2022)
Figure Asia-Pacific Biosimilar Monoclonal Antibodies (mAbs) Market Share by Type in 2022
Figure Asia-Pacific Biosimilar Monoclonal Antibodies (mAbs) Market Share by Application in 2022
Figure China Biosimilar Monoclonal Antibodies (mAbs) Sales and Growth Rate (2017-2022)
Figure China Biosimilar Monoclonal Antibodies (mAbs) Revenue (Million $) and Growth Rate (2017-2022)
Figure Japan Biosimilar Monoclonal Antibodies (mAbs) Sales and Growth Rate (2017-2022)
Figure Japan Biosimilar Monoclonal Antibodies (mAbs) Revenue (Million $) and Growth Rate (2017-2022)
Figure Korea Biosimilar Monoclonal Antibodies (mAbs) Sales and Growth Rate (2017-2022)
Figure Korea Biosimilar Monoclonal Antibodies (mAbs) Revenue (Million $) and Growth Rate (2017-2022)
Figure India Biosimilar Monoclonal Antibodies (mAbs) Sales and Growth Rate (2017-2022)
Figure India Biosimilar Monoclonal Antibodies (mAbs) Revenue (Million $) and Growth Rate (2017-2022)
Figure Southeast Asia Biosimilar Monoclonal Antibodies (mAbs) Sales and Growth Rate (2017-2022)
Figure Southeast Asia Biosimilar Monoclonal Antibodies (mAbs) Revenue (Million $) and Growth Rate (2017-2022)
Figure Australia Biosimilar Monoclonal Antibodies (mAbs) Sales and Growth Rate (2017-2022)
Figure Australia Biosimilar Monoclonal Antibodies (mAbs) Revenue (Million $) and Growth Rate (2017-2022)
Table South America Biosimilar Monoclonal Antibodies (mAbs) Sales by Country (2017-2022)
Figure South America Biosimilar Monoclonal Antibodies (mAbs) Sales Market Share by Country (2017-2022)
Table South America Biosimilar Monoclonal Antibodies (mAbs) Revenue by Country (2017-2022)
Figure South America Biosimilar Monoclonal Antibodies (mAbs) Revenue Market Share by Country (2017-2022)
Figure South America Biosimilar Monoclonal Antibodies (mAbs) Market Share by Type in 2022
Figure South America Biosimilar Monoclonal Antibodies (mAbs) Market Share by Application in 2022
Figure Brazil Biosimilar Monoclonal Antibodies (mAbs) Sales and Growth Rate (2017-2022)
Figure Brazil Biosimilar Monoclonal Antibodies (mAbs) Revenue (Million $) and Growth Rate (2017-2022)
Figure Argentina Biosimilar Monoclonal Antibodies (mAbs) Sales and Growth Rate (2017-2022)
Figure Argentina Biosimilar Monoclonal Antibodies (mAbs) Revenue (Million $) and Growth Rate (2017-2022)
Figure Colombia Biosimilar Monoclonal Antibodies (mAbs) Sales and Growth Rate (2017-2022)
Figure Colombia Biosimilar Monoclonal Antibodies (mAbs) Revenue (Million $) and Growth Rate (2017-2022)
Table Middle East & Africa Biosimilar Monoclonal Antibodies (mAbs) Sales by Country (2017-2022)
Figure Middle East & Africa Biosimilar Monoclonal Antibodies (mAbs) Sales Market Share by Country (2017-2022)
Table Middle East & Africa Biosimilar Monoclonal Antibodies (mAbs) Revenue by Country (2017-2022)
Figure Middle East & Africa Biosimilar Monoclonal Antibodies (mAbs) Revenue Market Share by Country (2017-2022)
Figure Middle East & Africa Biosimilar Monoclonal Antibodies (mAbs) Market Share by Type in 2022
Figure Middle East & Africa Biosimilar Monoclonal Antibodies (mAbs) Market Share by Application in 2022
Figure UAE Biosimilar Monoclonal Antibodies (mAbs) Sales and Growth Rate (2017-2022)
Figure UAE Biosimilar Monoclonal Antibodies (mAbs) Revenue (Million $) and Growth Rate (2017-2022)
Figure Saudi Arabia Biosimilar Monoclonal Antibodies (mAbs) Sales and Growth Rate (2017-2022)
Figure Saudi Arabia Biosimilar Monoclonal Antibodies (mAbs) Revenue (Million $) and Growth Rate (2017-2022)
Figure South Africa Biosimilar Monoclonal Antibodies (mAbs) Sales and Growth Rate (2017-2022)
Figure South Africa Biosimilar Monoclonal Antibodies (mAbs) Revenue (Million $) and Growth Rate (2017-2022)
Table Company Snapshot of Celltrion
Table Biosimilar Monoclonal Antibodies (mAbs) Introduction of Celltrion
Table Biosimilar Monoclonal Antibodies (mAbs) Sales, Price, Revenue, Gross Margin and Market Share of Celltrion (2020-2022)
Table Industrial Chain of Biosimilar Monoclonal Antibodies (mAbs)
Table Manufacturing Cost Structure of Biosimilar Monoclonal Antibodies (mAbs)
Table General Manufacturing Process of Biosimilar Monoclonal Antibodies (mAbs)
Table Leading Distributors/Dealers of Biosimilar Monoclonal Antibodies (mAbs)
Table Leading Consumers of Biosimilar Monoclonal Antibodies (mAbs)
Figure Global Biosimilar Monoclonal Antibodies (mAbs) Sales and Growth Rate Forecast (2023-2031)
Figure Global Biosimilar Monoclonal Antibodies (mAbs) Revenue and Growth Rate Forecast (2023-2031)
Table Global Biosimilar Monoclonal Antibodies (mAbs) Market Size and CAGR Forecast by Region (2023-2031)
Table Global Biosimilar Monoclonal Antibodies (mAbs) Market Size and CAGR Forecast by Type (2023-2031)
Table Global Biosimilar Monoclonal Antibodies (mAbs) Market Size and CAGR Forecast by Application (2023-2031)
Table Global Biosimilar Monoclonal Antibodies (mAbs) Market Size and CAGR Forecast by Sales Channel (2023-2031)
Industry Market Size
